发现抗体/1-EBIO/250 mg/E-150-250 mg

价格
¥4740.00
货号:E-150-250mg
浏览量:127
品牌:Discovery
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat #: E-150
Alternative Name 1-Ethyl-2-benzimidazolinone
  • Lyophilized Powder
  • Bioassay Tested
  • Source Synthetic
    MW: 162.19
    Purity: >97%
    Effective concentration 5-100 μM.
      • 1-EBIO
    Chemical name 3-ethyl-1H-benzimidazol-2-one.
    Molecular formula C9H10N2O.
    CAS No.: 10045-45-1.
    PubChem CID 82320
    Activity 1-EBIO is an activator of KCa3.1 and KCa2 channel currents1.
      • Waschk, D.E. et al. (2011) Am. J. Physiol. Cell. Physiol. 300, C843.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
    Solubility 250 mM DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
    Storage of solutions Up to four weeks at 4°C or three months at -20°C.
      • 1-EBIO
        Alomone Labs 1-EBIO activates KCa3.1 currents expressed in HEK 293T cells.
        A. Time course of KCa3.1 current amplitude and its activation by 50 µM 1-EBIO (#E-150). Currents were elicited by application of voltage ramp from -120 mV to +60 mV (150 msec), delivered every 10 seconds, holding potential of -80mV. B. Superimposed example traces of current responses before and during perfusion of 50 µM 1-EBIO as indicated.
    References - Scientific background
    • 1. Wong, R. et al. (2014) J. Neurosci. 34, 13371.
    • 2. Coleman, N. et al. (2014) Mol. Pharmacol. 86, 342.
    • 3. Strøbæk, D. et al. (2013) Br. J. Pharmacol. 168, 432.
      • 1-EBIO is a potent KCa2/3 channel activator that activates the channels by increasing the Ca2+ sensitivity by stabilizing the interaction between calmodulin and the channels1,2, thus shifting the activation curve of the channels to the left. 1-EBIO activates KCa3.1 with an EC50 value of around 30 μM and all three KCa2 channels with EC50 value around 300 μM2.

        The Ca2+-activated K+ channel, KCa3.1, plays a major role in the controlled expression of essential genes that are responsible for several physiological processes including- membrane potential, cell volume proliferation, migration and production of inflammatory mediators by participating in the regulation of calcium entry. A highly regulated and sustained increase in cytosolic Ca2+ is critical in these processes making KCa3.1 a potential target for therapy of several disease1,3.

    Target KCa3.1, KCa2 channels
    receive a 10 mg free trial sample!
    Last update: 02/12/2019

    1-EBIO (#E-150) is a highly pure, synthetic, and biologically active compound.

    For research purposes only, not for human use
    Discovery®抗体是Cambridge Research Biochemicals的目录抗体业务。 CRB是全球第二大最古老的肽公司,也是抗体研究市场的先驱,目前正以Discovery®Antibodies的名义建立一系列新验证的靶标抗体。 Discovery®抗体将专注于研究用抗体(早期药物“发现”),并将补充我们非常成功且长期存在的定制抗体业务(www.crbdiscovery.com)。我们已经以新颖,复杂,稀有和翻译后修饰的特异性抗体而闻名,这些受追捧的靶标将出现在我们的Discovery®Antibody目录范围内。  我们于2017年2月,在发现肽之后一年,并且在詹姆斯·库克船长(他当时最伟大的探险家)于1776年从英国出发,乘坐“ HMS发现”号开始租用新水域和“发现全球各地的新土地。因此,“发现”这个名称似乎适合东北制造商–詹姆斯·库克的故乡。 在1700年代后期对全球新发现土地的追求与医学研究的新“发现”以及2000年人类基因组图谱的发现之间,还有其他相似之处。  有关更多详细信息,请参见有关Discovery®抗体发布的新闻稿。   Cambridge Research Biochemicals  (www.crbdiscovery.com)成立于1980年,是英国领先的定制肽和抗体工具的独立生产商,为全球制药,生命科学和学术领域的研究人员提供产品。其产品的主要应用是定制的实验室规模试剂,用于早期药物发现中的主要研究证据,并支持临床研究中的生物标志物计划。该公司生产各种口味的肽,从简单到修饰,稳定和放射性标记,再到从毫克到克到最高纯度的染料标记。此外,CRB是产生高度特异性和靶向抗体(多克隆抗体和单克隆抗体)的公认专家。荧光染料标记也是重点。自1994年以来,该公司于2016年启动了其首个目录业务DISCOVERY®。
    • 资质认证

      获得国家资质,权威认证!

    • 全国联保

      全国联保,官方无忧售后

    • 正规发票

      正规发票,放心购买

    • 签订合同

      签订合同,保障您的权益

    /**/